IDENTIFICATION OF A NOVEL CANDIDATE BIOMARKER FOR DIAGNOSIS AND THERAPEUTIC OVARIAN CANCER TARGET

被引：0
|
作者：
Park, Kyoungsook [1 ]
Son, Chaeyeon [1 ]
Song, Sang Yong [1 ,2 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Suwon 16419, South Korea
[2] Samsung Med Ctr, Dept Pathol & Translat Genom, Biobank, Seoul 06351, South Korea
来源：
CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GMM-044
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [1] Identification of Novel Biomarker and Therapeutic Target Candidates for Diagnosis and Treatment of Follicular Adenoma
    Lai, Xianyin
    Chen, Shaoxiong
    [J]. CANCER GENOMICS & PROTEOMICS, 2015, 12 (06) : 271 - 281
  • [2] KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer
    Wang, Xingwei
    Sun, Ru
    Hong, Xia
    Chen, Chen
    Ding, Yan
    [J]. JOURNAL OF ONCOLOGY, 2022, 2022
  • [3] Identification of novel biomarker and therapeutic target candidates for diagnosis and treatment of follicular carcinoma
    Lai, Xianyin
    Umbricht, Christopher B.
    Fisher, Kurt
    Bishop, Justin
    Shi, Qiuying
    Chen, Shaoxiong
    [J]. JOURNAL OF PROTEOMICS, 2017, 166 : 59 - 67
  • [4] An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
    Alexandrova, Elena
    Pecoraro, Giovanni
    Sellitto, Assunta
    Melone, Viola
    Ferravante, Carlo
    Rocco, Teresa
    Guacci, Anna
    Giurato, Giorgio
    Nassa, Giovanni
    Rizzo, Francesca
    Weisz, Alessandro
    Tarallo, Roberta
    [J]. CANCERS, 2020, 12 (06) : 1 - 32
  • [5] PAD ENZYMES AS A CANDIDATE THERAPEUTIC TARGET IN OVARIAN CANCER
    O'Toole, S.
    Melarcode, H.
    Elbaruni, S.
    AbuSaadeh, F.
    Ward, M.
    Gallagher, M.
    Norris, L.
    Gray, S.
    O'Leary, J.
    Mohamed, B.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A496 - A497
  • [6] IDENTIFICATION OF LYSYL OXIDASE AS A DIAGNOSIS AND PROGNOSIS BIOMARKER AND A THERAPEUTIC TARGET IN LUNG CANCER
    Gao, Yijun
    Xiao, Qian
    Ma, Huimin
    Li, Li
    Liu, Jun
    Feng, Yan
    Fang, Zhaoyuan
    Wu, Jing
    Han, Xiangkun
    Zhang, Junhua
    Sun, Yihua
    Wu, Gongwei
    Padera, Robert
    Chen, Haiquan
    Wong, Kwok-Kin
    Ge, Gaoxiang
    Ji, Hongbin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S684 - S685
  • [7] Identification of URST4 as a novel biomarker and therapeutic target for oral cancer
    Zhu, Ming
    Takano, Atsushi
    Tsevegjav, Bayarbat
    Yoshitake, Yoshihiro
    Shinohara, Masanori
    Daigo, Yataro
    [J]. CANCER SCIENCE, 2021, 112 : 267 - 267
  • [8] FKBPL as a novel therapeutic target and prognostic biomarker in high grade serous ovarian cancer
    Annett, Stephanie
    Moore, Gillian
    Short, Amy
    Moustafa, Neermeen
    Das, Sudipto
    O'Connor, Darran
    McCrudden, Cian
    Kissenpfenning, Adrien
    Nelson, Laura
    Harley, Ian
    Arthur, Ken
    Yakkundi, Anita
    McCluggage, Glen
    Marshall, Andrea
    Furlong, Fiona
    McCarthy, Helen O.
    Cotton, Graham
    Harrison, Timothy
    McClements, Lana
    Robson, Tracy
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [9] MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
    Xu, Haoya
    Zou, Ruoyao
    Li, Feifei
    Liu, Jiyu
    Luan, Nannan
    Wang, Shengke
    Zhu, Liancheng
    [J]. CANCER MEDICINE, 2021, 10 (11): : 3655 - 3673
  • [10] Identification of AK4 as a novel therapeutic target for serous ovarian cancer
    Huang, Minmin
    Qin, Xinlei
    Wang, Yuwei
    Mao, Furong
    [J]. ONCOLOGY LETTERS, 2020, 20 (06)
12345